Samsung Bioepis' Enbrel drug copy gets EU approval

SEOUL (Reuters) - Samsung Bioepis Co Ltd said on Sunday it had received European Commission approval for its copy of the blockbuster biotech arthritis drug Enbrel.

http://ift.tt/1UYiwn4

from Reuters: Health News
via animenewspro